Deep search
Search
Copilot
Images
Videos
Maps
News
Shopping
More
Flights
Travel
Hotels
Notebook
Top stories
Sports
U.S.
Local
World
Science
Technology
Entertainment
Business
More
Politics
Any time
Past hour
Past 24 hours
Past 7 days
Past 30 days
Best match
Most recent
FDA Approves 1st Non-Opioid Pain Medicine in 20 Years
FDA approves first new type of pain medication in 25 years
The US Food and Drug Administration signed off Thursday on the first new type of pain reliever to be approved in more than two decades. The drug, suzetrigine, is a 50-milligram prescription pill that’s taken every 12 hours after a larger starter dose.
FDA approves painkiller designed to eliminate the risk of addiction associated with opioids
U.S. officials have approved a new type of pain drug designed to eliminate the risks of addiction and overdose associated with opioids.
What Is Journavx? First Pain Medication Approved by FDA in Over Two Decades
This milestone marks a breakthrough after unsuccessful attempts to develop painkillers without the addictive potential of opioids.
FDA, migraine and Symbravo
US FDA approves Axsome Therapeutics' migraine drug
The U.S. Food and Drug Administration has approved Axsome Therapeutics' migraine treatment, the company said on Thursday.
Axsome Therapeutics announces FDA approval of Symbravo
Axsome Therapeutics (AXSM) announced that the U.S. FDA has approved Symbravo for the acute treatment of migraine with or without aura in
FDA approves new migraine treatment SYMBRAVO
NEW YORK - Axsome Therapeutics, Inc. (NASDAQ:AXSM), a $5.28 billion biopharmaceutical company with impressive 51% revenue growth over the last twelve months, announced the U.S. Food and Drug Administration (FDA) has approved SYMBRAVO®,
FDA issues Class I on Lay's potato chips
Chocolate Recall Update As FDA Sets Highest Risk Level for 9 States
A recall which was issued across nine states has now been given the highest risk classification by the federal agency.
Lay’s potato chip recall elevated to FDA’s highest-risk classification
The FDA has upgraded a recall of Lay’s Potato Chips to the highest level possible, meaning consuming the chips will cause adverse health consequences. In December, Texas-based food manufacturer Frito Lay recalled a limited number of Lay’s Classic 13oz because the product could contain undeclared milk ingredients.
FDA reclassifies Lay’s potato chips recall to the highest risk level, warning the chips could cause ‘serious adverse health consequences or death’
The FDA has raised the risk level on a recall of Lay’s potato chips to the highest level, warning the recalled product could cause death. The chips were originally recalled last month for containing undeclared milk.
10h
US FDA identifies cybersecurity risks in certain patient monitors
The U.S. Food and Drug Administration (FDA) said on Thursday it had identified three cybersecurity risks associated with ...
2d
on MSN
FDA approves Ozempic to reduce risks from chronic kidney disease in diabetes patients
Ozempic, the blockbuster GLP-1 drug that was originally approved to treat type 2 diabetes, has now also been approved by the ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Trending now
Crash at Reagan airport
Los Angeles wildfire updates
Cause of death revealed
Asteroid may hit Earth
Signs education orders
Michigan priest loses license
Ex-worker admits to theft
Hamas confirms death
Blames DEI for crash
Accused of sexual misconduct
DOJ sues to block deal
Deputy shooting sentence
Wildfire erupts in NC
2 more victims in indictment
'As Tears Go By' singer dies
Searching for joyriders
DOJ weighs dropping case?
Ground stop amid IT outage
Senate confirmation hearing
First spacewalk together
Shiffrin finishes 10th
Hamas frees more hostages
Ebola outbreak in Uganda
Syria’s transitional pres
US economy grew 2.3%
Day 2 of Senate hearing
S3 release date revealed
Nashville bids for franchise
Weekly jobless claims fall
Related topics
Trump
Washington
United States
Food and Drug Administration
Journavx
Feedback